Recent research found that bvPLA2 therapy can change regulatory T-cell populations in a 3xTg-AD animal model
However, weight reduction is very difficult to accomplish and maintain
Beyond their effects on insulin secretion, accumulating evidence demonstrates that GLP-1 RAs also enhance insulin sensitivity and reduce systemic insulin resistance
A proper evaluation should look beyond the prescription itself
Further reinforcing this early and rapid inflammation reduction is that a lab measure called hsCRP, or high sensitivity C-reactive protein, was significantly reduced at 4 weeks as well, when patients had only lost 2.7% of their body weight
Amit Bansal Punit Bansal #WorldParkinsonsDay #Neurology #CNS #Lyophilization #DrugShortages #GlobalHealth #SterileInjectables #TheonPharma To view or add a comment, sign in Whats prescribed daily can still be dangerously underestimated when combined